.Vaxcyte introduced what analysts called "spectacular" phase 1/2 data for its 31-valent pneumococcal...
.Recursion has actually stumbled by means of an early exam of its tech-enabled strategy to drug reve...
.Phone it a situation of good chemistry: Acepodia, a biotech based on Nobel Champion scientific rese...
.Praxis Precision Medicines has actually racked up one more midphase succeed in epilepsy this year, ...
.After escaping a medical grip numerous years back, Dyne Therapeutics has actually revealed brand-ne...
.Arrowhead Pharmaceuticals has actually presented its own give ahead of a possible face-off along wi...
.Pfizer and also Valneva may possess about two even more years to wait before they produce the initi...
.Let's study a talk with Ayla Ellison, Fierce Biotech Managing Editor and Michelle Benz as they cove...
.Bayer put on hold the stage 3 test for its own aspect XIa inhibitor asundexian behind time in 2013 ...
.Sanofi is still set on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, execs have a...